Agenus reported $19.16M in Trade Creditors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acceleron Pharma XLRN:US $ 5.09M 4.35M
Amgen AMGN:US $ 1171M 106M
Bristol Myers Squibb BMY:US $ 2695M 914M
Celldex Therapeutics CLDX:US $ 0.84M 0.15M
Chemocentryx CCXI:US $ 4.41M 6.68M
CSL CSL:AU $ 2.04B 419.2M
Dicerna Pharmaceuticals DRNA:US $ 8.32M 4.51M
Dynavax Technologies DVAX:US $ 3.6M 8.48M
Eli Lilly And LLY:US $ 1566.8M 31M
Flexion Therapeutics FLXN:US $ 7.49M 2.02M
Genocea Biosciences GNCA:US $ 0.98M 0.38M
Intrexon XON:US $ 3.62M 1.31M
Jiangsu Hengrui Me. 600276:CH CH 1.43B 322.39M
Karyopharm Therapeutics KPTI:US $ 881K 1.43M
Macrogenics MGNX:US $ 6.17M 3.65M
Merck MRK:GR € 2132M 25M
Novartis NOVN:VX 4.66B 146M
Novavax NVAX:US $ 59.56M 14.43M
Regeneron Pharmaceuticals REGN:US $ 427M 49M
Rigel Pharmaceuticals RIGL:US $ 3.14M 1.46M
Sangamo Biosciences SGMO:US 7.98M 2.15M
Veracyte VCYT:US $ 11.2M 2.73M
YTE INCY:US $ 114.51M 7.59M